ELECTROPHYSIOLOGICAL EFFECTS OF NEURAL REMODELING OF THE VENTRICLES

$384,420R01FY2016HLNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

Paper 35932988 Paper 35242541 Paper 34454884 Paper 33786311 Paper 33665104 Paper 32360319 Paper 31834357 Paper 31671074 Paper 31028266 Paper 30979606 Paper 30871703 Paper 30820399 Paper 30562104 Paper 30414637 Paper 30336882 Paper 30246802 Paper 30216122 Paper 30206483 Paper 29931207 Paper 29759718 Paper 29759536 Paper 29709577 Paper 29454137 Paper 29451372 Paper 29275376 Paper 29270467 Paper 29132931 Paper 29017930 Paper 28931760 Paper 28917555 Paper 28843418 Paper 28802636 Paper 28641796 Paper 28506710 Paper 28434447 Paper 28408652 Paper 28358748 Paper 28082527 Paper 27782943 Paper 27556589 Paper 27516464 Paper 27417670 Paper 27344272 Paper 27209472 Paper 27114333 Paper 26969783 Paper 26955520 Paper 26661096 Paper 26643285 Paper 26572244 Paper 26498260 Paper 26487628 Paper 26383723 Paper 26371172 Paper 26306131 Paper 26282244 Paper 26272522 Paper 26054327 Paper 26051207 Paper 26044253 Paper 26031376 Paper 25943537 Paper 25894588 Paper 25873718 Paper 25870562 Paper 25814410 Paper 25804262 Paper 25772155 Paper 25745476 Paper 25740836 Paper 25640636 Paper 25609901 Paper 25532528 Paper 25516575 Paper 25485779 Paper 25285644 Paper 25057218 Paper 25017919 Paper 25015962 Paper 25007089 Paper 24948520 Paper 24946895 Paper 24797604 Paper 24724798 Paper 24657687 Paper 24632280 Paper 24568826 Paper 24561143 Paper 24532564 Paper 24427121 Paper 24389229 Paper 24291775 Paper 24290748 Paper 24162832 Paper 23893168 Paper 23893167 Paper 23873142 Paper 23661621 Paper 23643678 Paper 23611057

Abstract

DESCRIPTION (provided by applicant): Sudden cardiac death (SCD) due to ventricular arrhythmias is the leading cause of mortality in the United States, resulting in 250,000 deaths/year. The autonomic nervous system plays a major role in the pathophysiology of arrhythmias leading to SCD and neuraxial modulation provides an important venue for therapeutic intervention. The major goal of our research is to investigate the role of cardiac sympathetic innervations in the genesis of arrhythmias, and that of neuraxial modulation in prevention of these arrhythmias in humans. The mechanisms underlying sympathetic control of myocardial excitability in normal and diseased human hearts, and specifically, regional differences (apex versus base, epicardium versus endocardium, right versus left stellate ganglion innervation) remain unknown and need to be studied. Further, myocardial scars seen in ischemic and non-ischemic cardiomyopathy show nerve sprouting at the border zone of scars due to neural remodeling, which has been implicated in the pathophysiology of ventricular arrhythmias. The functional effects of nerve stimulation in this setting and how neuraxial blockade works in humans in these diseases are still unknown and this knowledge can help guide therapy. In this proposal, electrophysiological effects of direct regional cardiac nerve stimulation and neuraxial modulation of the thoracic sympathetic ganglia will be investigated. Areas of the heart regulated by the right and left stellate ganglia will be delineated in patients undergoing interventional electrophysiology procedures and cardiac transplantation. Understanding neuraxial modulation has the potential to further develop therapies that target these pathways in the very near term. Therapies such as right, left, or bilateral cerviocothoracic sympathectomy which has been 're-introduced' into clinical practice (by our group and others) already show a lot of promise and could emerge as novel/elegant therapies that are also cost-effective for the prevention of SCD. Therefore, neuraxial modulation is an approach that has the potential to have a global impact given the prohibitive high cost and morbidity associated with implantable defibrillators which prevent their expanded use.

View original record on NIH RePORTER →